BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Bayer Oncology Dubs American Society of Clinical Oncology "Turning Point" for Cancer Efforts


6/6/2012 8:28:01 AM

If one were to list the top cancer drugmakers of all time, it’s fair to say Bayer wouldn’t make the top 10. Despite the German drug giant’s leadership position across the healthcare spectrum—from over-the-counter aspirin to diabetes glucose-testing meters—it has never made much of a splash in cancer. In 2000, Bayer’s (OTCBB: BAYRY) top executives decided to change that by making a major commitment to oncology and boosting its cancer development efforts in a few key sites, including its R&D facility in Montville, NJ.

Read at Xconomy


Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->